JP2008500385A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2008500385A5 JP2008500385A5 JP2007521014A JP2007521014A JP2008500385A5 JP 2008500385 A5 JP2008500385 A5 JP 2008500385A5 JP 2007521014 A JP2007521014 A JP 2007521014A JP 2007521014 A JP2007521014 A JP 2007521014A JP 2008500385 A5 JP2008500385 A5 JP 2008500385A5
- Authority
- JP
- Japan
- Prior art keywords
- chloronaphthalen
- sulfonyl
- hydroxypropanoyl
- salt
- piperidin
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2004152000 | 2004-05-21 | ||
| PCT/JP2005/009711 WO2005113504A1 (en) | 2004-05-21 | 2005-05-20 | Cyclic amide derivatives, and their production and use as antithrombotic agents |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2008006003A Division JP4362535B2 (ja) | 2004-05-21 | 2008-01-15 | 環状アミド誘導体、その製造法および抗血栓剤としての用途 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2008500385A JP2008500385A (ja) | 2008-01-10 |
| JP2008500385A5 true JP2008500385A5 (en:Method) | 2008-02-28 |
| JP4129047B2 JP4129047B2 (ja) | 2008-07-30 |
Family
ID=34968275
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2007521014A Expired - Fee Related JP4129047B2 (ja) | 2004-05-21 | 2005-05-20 | 環状アミド誘導体、その製造法および抗血栓剤としての用途 |
| JP2008006003A Expired - Fee Related JP4362535B2 (ja) | 2004-05-21 | 2008-01-15 | 環状アミド誘導体、その製造法および抗血栓剤としての用途 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2008006003A Expired - Fee Related JP4362535B2 (ja) | 2004-05-21 | 2008-01-15 | 環状アミド誘導体、その製造法および抗血栓剤としての用途 |
Country Status (26)
| Country | Link |
|---|---|
| US (4) | US7745623B2 (en:Method) |
| EP (2) | EP1748985B1 (en:Method) |
| JP (2) | JP4129047B2 (en:Method) |
| KR (1) | KR101248637B1 (en:Method) |
| CN (2) | CN102093285B (en:Method) |
| AT (1) | ATE513813T1 (en:Method) |
| AU (1) | AU2005245298B2 (en:Method) |
| BR (1) | BRPI0511186A (en:Method) |
| CA (1) | CA2567506C (en:Method) |
| CY (1) | CY1111850T1 (en:Method) |
| DK (1) | DK1748985T3 (en:Method) |
| ES (1) | ES2368155T3 (en:Method) |
| HR (1) | HRP20110640T1 (en:Method) |
| IL (1) | IL178896A (en:Method) |
| MX (1) | MXPA06013243A (en:Method) |
| MY (1) | MY154461A (en:Method) |
| NO (1) | NO20065929L (en:Method) |
| NZ (1) | NZ550985A (en:Method) |
| PH (1) | PH12012501331A1 (en:Method) |
| PL (1) | PL1748985T3 (en:Method) |
| PT (1) | PT1748985E (en:Method) |
| RS (1) | RS51925B (en:Method) |
| RU (1) | RU2361861C2 (en:Method) |
| SI (1) | SI1748985T1 (en:Method) |
| TW (1) | TWI396686B (en:Method) |
| WO (1) | WO2005113504A1 (en:Method) |
Families Citing this family (74)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20030187023A1 (en) * | 2000-07-17 | 2003-10-02 | Keiji Kubo | Sulfone derivatives, process for their production and use thereof |
| WO2004048363A1 (ja) * | 2002-11-22 | 2004-06-10 | Takeda Pharmaceutical Company Limited | イミダゾール誘導体、その製造法および用途 |
| TWI396686B (zh) * | 2004-05-21 | 2013-05-21 | Takeda Pharmaceutical | 環狀醯胺衍生物、以及其製品和用法 |
| JP2009517406A (ja) * | 2005-11-28 | 2009-04-30 | ザイモジェネティクス， インコーポレイテッド | Ｉｌ−２１受容体アンタゴニスト |
| US20110045028A1 (en) * | 2006-11-30 | 2011-02-24 | Takeda Pharmaceutical Company Limited | Sustained release preparation |
| AR073380A1 (es) | 2008-09-25 | 2010-11-03 | Takeda Pharmaceutical | Composicion farmaceutica solida. comprimido multicapa |
| JP5535931B2 (ja) | 2008-10-27 | 2014-07-02 | 武田薬品工業株式会社 | 二環性化合物 |
| WO2010076884A1 (ja) | 2008-12-29 | 2010-07-08 | 武田薬品工業株式会社 | 新規縮合環化合物およびその用途 |
| US20100190747A1 (en) | 2009-01-27 | 2010-07-29 | Hideo Suzuki | Fused ring compound and use thereof |
| CA2760073A1 (en) | 2009-04-30 | 2010-11-04 | Takeda Pharmaceutical Company Limited | Solid preparation |
| WO2010143733A1 (en) | 2009-06-09 | 2010-12-16 | Takeda Pharmaceutical Company Limited | Novel fused cyclic compound and use thereof |
| BR112012001959A2 (pt) | 2009-07-28 | 2016-03-15 | Takeda Pharmaceutical | comprimido,e, método para reproduzir um comprimido |
| US8221489B2 (en) * | 2009-08-20 | 2012-07-17 | Stentys | Device and method for treating a body lumen |
| CN103025716B (zh) | 2010-04-27 | 2014-12-24 | 武田药品工业株式会社 | 二环化合物衍生物及其作为acc抑制剂的用途 |
| ES2524896T3 (es) | 2010-06-16 | 2014-12-15 | Takeda Pharmaceutical Company Limited | Cristal de compuesto de amida |
| CA2806258A1 (en) | 2010-07-23 | 2012-01-26 | Takeda Pharmaceutical Company Limited | Fused heterocyclic compound and application thereof |
| EP2617726A4 (en) | 2010-09-17 | 2014-05-14 | Takeda Pharmaceutical | DIABETES THERAPEUTIC |
| US8729102B2 (en) | 2010-11-30 | 2014-05-20 | Takeda Pharmaceutical Company Limited | Bicyclic compound |
| WO2012111849A1 (en) | 2011-02-17 | 2012-08-23 | Takeda Pharmaceutical Company Limited | Production method of optically active dihydrobenzofuran derivative |
| CA2853221A1 (en) | 2011-10-24 | 2013-05-02 | Tohru Yamashita | Bicyclic compound |
| WO2013105676A1 (en) | 2012-01-12 | 2013-07-18 | Takeda Pharmaceutical Company Limited | Benzimidazole derivatives as mch receptor antagonists |
| US9382188B2 (en) | 2012-02-13 | 2016-07-05 | Takeda Pharmaceutical Company Limited | Aromatic ring compound |
| EP2816032A4 (en) | 2012-02-13 | 2015-09-30 | Takeda Pharmaceutical | AROMATIC RING CONNECTION |
| WO2013122260A1 (en) | 2012-02-15 | 2013-08-22 | Takeda Pharmaceutical Company Limited | Tablet |
| US9238639B2 (en) | 2012-02-24 | 2016-01-19 | Takeda Pharmaceutical Company Limited | Aromatic ring compound |
| US9073864B2 (en) | 2012-03-29 | 2015-07-07 | Takeda Pharmaceutical Company Limted | Aromatic ring compound |
| US9440987B2 (en) | 2012-05-10 | 2016-09-13 | Takeda Pharmaceutical Company Limited | Aromatic ring compound |
| EP2848622A4 (en) | 2012-05-10 | 2015-11-04 | Takeda Pharmaceutical | Aromatic ring compound |
| JP6122879B2 (ja) | 2012-06-05 | 2017-04-26 | 武田薬品工業株式会社 | 固形製剤 |
| JP2015127299A (ja) | 2012-07-19 | 2015-07-09 | 武田薬品工業株式会社 | 固形製剤 |
| US20150299188A1 (en) | 2012-08-24 | 2015-10-22 | Takeda Pharmaceutical Company Limited | Heterocyclic compound |
| CN103936763B (zh) * | 2013-01-18 | 2017-10-31 | 中国科学院上海药物研究所 | 噁唑烷酮类化合物及其制备方法和用途 |
| JP6247697B2 (ja) | 2013-03-14 | 2017-12-13 | 武田薬品工業株式会社 | スピロアゼチジンイソキサゾール誘導体及びそのｓｓｔｒ５アンタゴニストとしての使用 |
| US10005720B2 (en) | 2013-04-05 | 2018-06-26 | North Carolina Central University | Compounds useful for the treatment of metabolic disorders and synthesis of the same |
| AR096848A1 (es) | 2013-07-09 | 2016-02-03 | Takeda Pharmaceuticals Co | Derivados de indazol con actividad antagonista del receptor de la hormona concentradora de melanina (mch) |
| JP6397410B2 (ja) | 2013-08-09 | 2018-09-26 | 武田薬品工業株式会社 | 芳香環化合物 |
| JO3442B1 (ar) | 2013-10-07 | 2019-10-20 | Takeda Pharmaceuticals Co | مضادات ذات نوع فرعي من مستقبل سوماتوستاتين 5 (sstr5) |
| US9428470B2 (en) | 2014-02-13 | 2016-08-30 | Takeda Pharmaceutical Company Limited | Heterocyclic compound |
| US9346776B2 (en) | 2014-02-13 | 2016-05-24 | Takeda Pharmaceutical Company Limited | Fused heterocyclic compound |
| WO2016045587A1 (zh) * | 2014-09-26 | 2016-03-31 | 常州寅盛药业有限公司 | 作为ns4b抑制剂的苯并呋喃类似物 |
| EP3237390B1 (en) | 2014-12-23 | 2019-05-08 | Crossing S.r.l. | Method for the industrial production of 2-halo-4,6-dialkoxy-1,3,5-triazine and their use in the presence of amines |
| JOP20190211A1 (ar) | 2017-03-31 | 2019-09-15 | Takeda Pharmaceuticals Co | ببتيد منشط لمستقبل gip |
| AR111199A1 (es) | 2017-03-31 | 2019-06-12 | Takeda Pharmaceuticals Co | Compuesto aromático agonista de gpr40 |
| WO2018181847A1 (ja) | 2017-03-31 | 2018-10-04 | 武田薬品工業株式会社 | 芳香環化合物 |
| EP3654968B1 (en) | 2017-07-17 | 2023-08-16 | Merck Sharp & Dohme LLC | Metallo-beta-lactamase inhibitors and methods of use thereof |
| AU2019237507B2 (en) | 2018-03-23 | 2025-04-03 | Carmot Therapeutics, Inc. | Modulators of G-protein coupled receptors |
| WO2020045326A1 (ja) | 2018-08-27 | 2020-03-05 | 株式会社スコヒアファーマ | 安息香酸エステル化合物 |
| JP2022503793A (ja) | 2018-09-24 | 2022-01-12 | 武田薬品工業株式会社 | Ｇｉｐ受容体アゴニストペプチド化合物及びその使用 |
| WO2020067575A1 (en) | 2018-09-24 | 2020-04-02 | Takeda Pharmaceutical Company Limited | Gip receptor agonist peptide compounds and uses thereof |
| PE20231066A1 (es) | 2020-02-07 | 2023-07-17 | Gasherbrum Bio Inc | Agonistas heterociclicos de glp-1 |
| CA3172241A1 (en) | 2020-03-25 | 2021-09-30 | Antoine Charles Olivier HENNINOT | Qw dosing of gip receptor agonist peptide compounds and uses thereof |
| JP2023519446A (ja) | 2020-03-25 | 2023-05-10 | 武田薬品工業株式会社 | Ｇｉｐ受容体アゴニストペプチド化合物のｑｄ投薬及びその使用 |
| EP4143183B1 (en) | 2020-04-29 | 2025-10-22 | Gasherbrum Bio, Inc. | Heterocyclic glp-1 agonists |
| IL308392A (en) | 2021-05-13 | 2024-01-01 | Carmot Therapeutics Inc | G protein-coupled receptor modulators |
| JP2025509281A (ja) | 2022-03-09 | 2025-04-11 | ガシャーブラム・バイオ・インコーポレイテッド | ヘテロ環式ｇｌｐ－１アゴニスト |
| EP4496797A1 (en) | 2022-03-21 | 2025-01-29 | Gasherbrum Bio, Inc. | 5,8-dihydro-1,7-naphthyridine derivatives as glp-1 agonists for the treatment of diabetes |
| EP4508047A1 (en) | 2022-04-14 | 2025-02-19 | Gasherbrum Bio, Inc. | Heterocyclic glp-1 agonists |
| KR20250157491A (ko) | 2022-12-15 | 2025-11-04 | 가셔브룸 바이오, 인크. | Glp-1 효능제 활성을 갖는 화합물의 염 및 고체 형태 |
| EP4638440A1 (en) | 2022-12-22 | 2025-10-29 | Gasherbrum Bio, Inc. | Heterocyclic glp-1 agonists |
| CN120693338A (zh) | 2022-12-22 | 2025-09-23 | 加舒布鲁姆生物公司 | 杂环的glp-1激动剂 |
| IL322686A (en) | 2023-02-16 | 2025-10-01 | Gasherbrum Bio Inc | Heterocyclic glp-1 agonists |
| CN121773120A (zh) | 2023-06-30 | 2026-03-31 | 加舒布鲁姆生物公司 | 杂环glp-1激动剂 |
| EP4743174A1 (en) | 2023-07-13 | 2026-05-20 | Aconcagua Bio Inc | CALCITONIN AND/OR AMYLIN RECEPTOR ACTIVITY MODULATORS |
| AR133241A1 (es) | 2023-07-13 | 2025-09-10 | Aconcagua Bio Inc | Compuestos, composiciones y métodos |
| WO2025045208A1 (en) | 2023-08-31 | 2025-03-06 | Gasherbrum Bio, Inc. | Heteroaryl-heterocycloalkyl-based glp-1 agonists |
| WO2025137307A1 (en) | 2023-12-20 | 2025-06-26 | Gasherbrum Bio, Inc. | Heterocyclic glp-1 agonists |
| WO2025154020A1 (en) | 2024-01-19 | 2025-07-24 | Takeda Pharmaceutical Company Limited | Improved gip receptor agonist peptide compounds and uses thereof |
| WO2025154021A1 (en) | 2024-01-19 | 2025-07-24 | Takeda Pharmaceutical Company Limited | Improved gip receptor agonist peptide compounds and uses thereof |
| WO2025171340A1 (en) | 2024-02-08 | 2025-08-14 | Aconcagua Bio, Inc. | The treatment of calcitonin- and/or amylin-receptor associated conditions |
| WO2025171341A2 (en) | 2024-02-08 | 2025-08-14 | Aconcagua Bio, Inc. | Compounds and compositions for treating conditions associated with calcitonin receptor and/or amylin receptor activity |
| WO2025189141A1 (en) | 2024-03-08 | 2025-09-12 | Annapurna Bio, Inc. | Methods for treating obesity and increasing weight loss |
| WO2026041075A1 (en) | 2024-08-21 | 2026-02-26 | Gasherbrum Bio, Inc. | Gpl-1 agonists |
| WO2026051998A1 (en) | 2024-09-04 | 2026-03-12 | Aconcagua Bio, Inc. | Compounds, compositions, and methods |
| WO2026096926A1 (en) | 2024-11-01 | 2026-05-07 | Aconcagua Bio, Inc. | Compounds, compositions, and methods |
Family Cites Families (87)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US270488A (en) * | 1883-01-09 | Drilling apparatus | ||
| US2201270A (en) * | 1936-04-17 | 1940-05-21 | Mcintyre John Taylor | Apparatus for allaying dust from rock drills |
| US2946565A (en) * | 1953-06-16 | 1960-07-26 | Jersey Prod Res Co | Combination drilling and testing process |
| US2849214A (en) * | 1954-09-02 | 1958-08-26 | Gulf Research Development Co | Borehole drilling apparatus for preventing lost circulation |
| US3497020A (en) * | 1968-05-20 | 1970-02-24 | Archer W Kammerer Jr | System for reducing hydrostatic pressure on formations |
| JPS5011391B1 (en:Method) * | 1970-07-21 | 1975-04-30 | ||
| SE355840B (en:Method) * | 1971-09-08 | 1973-05-07 | Atlas Copco Ab | |
| FR2228301B1 (en:Method) | 1973-05-03 | 1977-10-14 | Ibm | |
| US4147786A (en) * | 1976-02-02 | 1979-04-03 | Ciba-Geigy Corporation | 1-Indolylalkyl-3-or 4-trimethyleneurido-piperidines |
| FI782133A7 (fi) * | 1977-07-08 | 1979-01-09 | Ciba Geigy Ag | Piperidino-propanoler och foerfarande foer deras framstaellning |
| EP0000485A1 (de) | 1977-07-08 | 1979-02-07 | Ciba-Geigy Ag | Piperidino-propanole, ihre Herstellung und pharmazeutische Präparate die diese enthalten |
| US4329348A (en) * | 1979-02-26 | 1982-05-11 | Ciba-Geigy Corporation | N-Oxacyclic-alkylpiperidines as psychostimulants |
| US4630691A (en) * | 1983-05-19 | 1986-12-23 | Hooper David W | Annulus bypass peripheral nozzle jet pump pressure differential drilling tool and method for well drilling |
| US4534426A (en) * | 1983-08-24 | 1985-08-13 | Unique Oil Tools, Inc. | Packer weighted and pressure differential method and apparatus for Big Hole drilling |
| US4567954A (en) * | 1983-12-02 | 1986-02-04 | Norton Christensen, Inc. | Replaceable nozzles for insertion into a drilling bit formed by powder metallurgical techniques and a method for manufacturing the same |
| US4695575A (en) * | 1984-11-13 | 1987-09-22 | Janssen Pharmaceutica, N.V. | 4-[(bicycle heterocyclyl)-methyl and -hetero]-piperidines |
| ZA928276B (en) | 1991-10-31 | 1993-05-06 | Daiichi Seiyaku Co | Aromatic amidine derivates and salts thereof. |
| US5902272A (en) * | 1992-01-07 | 1999-05-11 | Arthrocare Corporation | Planar ablation probe and method for electrosurgical cutting and ablation |
| US5595872A (en) * | 1992-03-06 | 1997-01-21 | Bristol-Myers Squibb Company | Nucleic acids encoding microsomal trigyceride transfer protein |
| ZA931601B (en) | 1992-03-06 | 1993-10-05 | Squibb & Sons Inc | Microsomal triglyceride transfer protein |
| US5355967A (en) * | 1992-10-30 | 1994-10-18 | Union Oil Company Of California | Underbalance jet pump drilling method |
| GB9321557D0 (en) * | 1992-11-03 | 1993-12-08 | Zeneca Ltd | Carboxamide derivatives |
| GB9312806D0 (en) | 1993-06-22 | 1993-08-04 | Boots Co Plc | Therapeutic agents |
| GB9317104D0 (en) * | 1993-08-17 | 1993-09-29 | Zeneca Ltd | Therapeutic heterocycles |
| TW394760B (en) | 1993-09-07 | 2000-06-21 | Hoffmann La Roche | Novel Carboxamides, process for their preparation and pharmaceutical composition containing the same |
| ZA951617B (en) * | 1994-03-04 | 1997-02-27 | Lilly Co Eli | Antithrombotic agents. |
| US5456326A (en) * | 1994-04-18 | 1995-10-10 | Exxon Production Research Company | Apparatus and method for installing open-ended tubular members axially into the earth |
| IL115420A0 (en) | 1994-09-26 | 1995-12-31 | Zeneca Ltd | Aminoheterocyclic derivatives |
| EP0786997A4 (en) | 1994-10-27 | 1998-03-11 | Merck & Co Inc | MUSCARINE ANTAGONISTS |
| NZ296210A (en) | 1994-12-02 | 1998-05-27 | Yamanouchi Pharma Co Ltd | Amidinonaphthyl derivatives to inhibit activated blood coagulation factor x |
| GB9508786D0 (en) * | 1995-04-29 | 1995-06-21 | Zeneca Ltd | Substituted heterocycles |
| EP0828754B1 (en) * | 1995-05-29 | 2005-02-02 | Pfizer Inc. | Dipeptides which promote release of growth hormone |
| US5612353A (en) | 1995-06-07 | 1997-03-18 | Rhone-Poulenc Rorer Pharmaceuticals Inc. | Substituted (sulfinic acid, sulfonic acid, sulfonylamino or sulfinylamino) N-[(aminoiminomethyl)phenylalkyl]-azaheterocyclylamide compounds |
| US5849759A (en) | 1995-12-08 | 1998-12-15 | Berlex Laboratories, Inc. | Naphthyl-substituted benzimidazole derivatives as anti-coagulants |
| GB9602294D0 (en) | 1996-02-05 | 1996-04-03 | Zeneca Ltd | Heterocyclic compounds |
| AU754936B2 (en) | 1996-11-27 | 2002-11-28 | Aventis Pharmaceuticals Inc. | Pharmaceutical composition comprising a compound having anti-Xa activity and a platelet aggregation antagonist compound |
| WO1998054164A1 (en) | 1997-05-30 | 1998-12-03 | Takeda Chemical Industries, Ltd. | Sulfonamide derivatives, their production and use |
| FR2764511B1 (fr) | 1997-06-13 | 2000-09-08 | Sanofi Sa | Compositions pour le traitement et la prevention de la thrombose arterielle et utilisation d'un inhibiteur du facteur xa seul et/ou en combinaison avec un antiagregant plaquettaire |
| GB9715895D0 (en) | 1997-07-29 | 1997-10-01 | Zeneca Ltd | Heterocyclic compounds |
| CA2310330A1 (en) | 1997-11-20 | 1999-06-03 | Teijin Limited | Biphenylamidine derivatives |
| CA2309558C (en) | 1997-11-21 | 2005-05-03 | Schering Corporation | Substituted oximes as neurokinin antagonists |
| CA2318351A1 (en) | 1997-12-26 | 1999-07-08 | Hidemitsu Nishida | Aromatic compounds having cyclic amino or salts thereof |
| US6403595B1 (en) * | 1998-02-05 | 2002-06-11 | Takeda Chemical Industries, Ltd. | Sulfonamide derivatives, processes for producing the same and utilization thereof |
| TR200002904T2 (tr) * | 1998-04-10 | 2001-02-21 | Japan Tobacco Inc. | Amidin bileşikleri |
| US6129152A (en) * | 1998-04-29 | 2000-10-10 | Alpine Oil Services Inc. | Rotating bop and method |
| GB9809349D0 (en) | 1998-05-02 | 1998-07-01 | Zeneca Ltd | Heterocyclic derivatives |
| US6423519B1 (en) * | 1998-07-15 | 2002-07-23 | Gpc Biotech Inc. | Compositions and methods for inhibiting fungal growth |
| CA2340100A1 (en) | 1998-08-11 | 2000-02-24 | Daiichi Pharmaceutical Co., Ltd. | Novel sulfonyl derivatives |
| JP2000080046A (ja) | 1998-09-03 | 2000-03-21 | Dai Ichi Seiyaku Co Ltd | 多臓器障害の予防・治療剤 |
| WO2000018398A1 (en) | 1998-09-25 | 2000-04-06 | Sunol Molecular Corporation | Pharmaceutically active compounds and methods of use thereof |
| AR021968A1 (es) | 1998-12-23 | 2002-09-04 | Schering Corp | Oximas e hidrazonas sustituidas como antagonistas de neuroquinina |
| US6204265B1 (en) * | 1998-12-23 | 2001-03-20 | Schering Corporation | Substituted oximes and hydrazones as neurokinin antagonists |
| US7217714B1 (en) | 1998-12-23 | 2007-05-15 | Agouron Pharmaceuticals, Inc. | CCR5 modulators |
| AU5566300A (en) | 1999-06-22 | 2001-01-09 | Takeda Chemical Industries Ltd. | Acylhydrazine derivatives, process for preparing the same and use thereof |
| DE60015541T2 (de) | 1999-06-30 | 2005-12-08 | Mochida Pharmaceutical Co. Ltd. | Trizyklische verbindungen mit einer spiro-einheit |
| CA2382755A1 (en) | 1999-07-28 | 2001-02-01 | Aventis Pharmaceuticals Products Inc. | Substituted oxoazaheterocyclyl compounds |
| AU7354900A (en) | 1999-09-09 | 2001-04-10 | Merck & Co., Inc. | Inhibitors of prenyl-protein transferase |
| CA2394639A1 (en) | 1999-12-15 | 2001-06-21 | Danny Peter Claude Mcgee | Salicylamides as serine protease and factor xa inhibitors |
| US6629974B2 (en) * | 2000-02-22 | 2003-10-07 | Gyrus Medical Limited | Tissue treatment method |
| US6723091B2 (en) * | 2000-02-22 | 2004-04-20 | Gyrus Medical Limited | Tissue resurfacing |
| AR033517A1 (es) | 2000-04-08 | 2003-12-26 | Astrazeneca Ab | Derivados de piperidina, proceso para su preparacion y uso de estos derivados en la fabricacion de medicamentos |
| US20030187023A1 (en) * | 2000-07-17 | 2003-10-02 | Keiji Kubo | Sulfone derivatives, process for their production and use thereof |
| JP2002201178A (ja) * | 2000-07-17 | 2002-07-16 | Takeda Chem Ind Ltd | スルホン誘導体、その製造法及び用途 |
| US6511973B2 (en) * | 2000-08-02 | 2003-01-28 | Bristol-Myers Squibb Co. | Lactam inhibitors of FXa and method |
| US20040082786A1 (en) | 2000-09-29 | 2004-04-29 | Bing-Yan Zhu | Piperazine based inhibitors of factor xa |
| AU2002222328A1 (en) * | 2000-10-18 | 2002-04-29 | Gian Franco Bernabei | Method and apparatus for plasma skin resurfacing |
| FR2819511A1 (fr) | 2001-01-18 | 2002-07-19 | Servier Lab | Nouveaux composes azepane, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
| JPWO2002068407A1 (ja) | 2001-02-28 | 2004-06-24 | 山之内製薬株式会社 | ベンゾイミダゾール化合物 |
| EP1409479B1 (en) | 2001-07-26 | 2008-01-23 | Eli Lilly And Company | 1-glycinyl-4-(1-methylpiperidin-4-yl)piperazines and -piperidines as factor xa antagonists |
| US6877571B2 (en) * | 2001-09-04 | 2005-04-12 | Sunstone Corporation | Down hole drilling assembly with independent jet pump |
| US7115741B2 (en) | 2001-09-06 | 2006-10-03 | Levy Daniel E | 4-thieno[2,3-D]pyrimidin-4-YL piperazine compounds |
| EP1427415B1 (en) | 2001-09-21 | 2009-08-12 | Brystol-Myers Squibb Company | Lactam-containing compounds and derivatives thereof as factor xa inhibitors |
| EP2243776A1 (en) * | 2001-10-12 | 2010-10-27 | High Point Pharmaceuticals, LLC | Substituted piperidines and their use for the treatment of diseases related to the histamine H3 receptor |
| DE10155075A1 (de) * | 2001-11-09 | 2003-05-22 | Merck Patent Gmbh | Cyclische Sulfonamide |
| ATE454381T1 (de) | 2002-03-28 | 2010-01-15 | Mitsubishi Tanabe Pharma Corp | Benzofuranderivat |
| TW200307667A (en) * | 2002-05-06 | 2003-12-16 | Bristol Myers Squibb Co | Sulfonylaminovalerolactams and derivatives thereof as factor Xa inhibitors |
| DE10229070A1 (de) | 2002-06-28 | 2004-01-15 | Merck Patent Gmbh | Phenylderivate 5 |
| US20040006490A1 (en) | 2002-07-08 | 2004-01-08 | Gingrich Mark A. | Prescription data exchange system |
| AU2003279735A1 (en) | 2002-10-02 | 2004-04-23 | Bristol-Myers Squibb Company | Lactam-containing diaminoalkyl, beta-aminoacids, alpha-aminoacids and derivatives thereof as factor xa inhibitors |
| AU2003271185A1 (en) | 2002-10-15 | 2004-05-04 | Takeda Pharmaceutical Company Limited | Imidazopyridine derivative, process for producing the same, and use |
| WO2004048363A1 (ja) * | 2002-11-22 | 2004-06-10 | Takeda Pharmaceutical Company Limited | イミダゾール誘導体、その製造法および用途 |
| CA2516234A1 (en) * | 2003-02-21 | 2004-09-02 | Pfizer Inc. | N-heterocyclyl-substituted amino-thiazole derivatives as protein kinase inhibitors |
| US6899188B2 (en) * | 2003-03-26 | 2005-05-31 | Sunstone Corporation | Down hole drilling assembly with concentric casing actuated jet pump |
| WO2005087266A1 (en) | 2004-03-05 | 2005-09-22 | Vddi Pharmaceuticals | Combination therapy for inhibition of platelet aggregation |
| TWI396686B (zh) * | 2004-05-21 | 2013-05-21 | Takeda Pharmaceutical | 環狀醯胺衍生物、以及其製品和用法 |
| US7988933B2 (en) | 2006-09-01 | 2011-08-02 | Siemens Healthcare Diagnostics Inc. | Identification system for a clinical sample container |
| KR100906250B1 (ko) | 2006-09-04 | 2009-07-07 | 주식회사 엘지화학 | 바인더로서 고중합도 폴리비닐알콜과 폴리비닐피롤리돈의혼합물을 포함하는 전극 합제 및 이를 포함하는 리튬이차전지 |
-
2005
- 2005-05-19 TW TW094116243A patent/TWI396686B/zh not_active IP Right Cessation
- 2005-05-20 AT AT05743594T patent/ATE513813T1/de active
- 2005-05-20 BR BRPI0511186-2A patent/BRPI0511186A/pt not_active Application Discontinuation
- 2005-05-20 EP EP05743594A patent/EP1748985B1/en not_active Expired - Lifetime
- 2005-05-20 SI SI200531321T patent/SI1748985T1/sl unknown
- 2005-05-20 NZ NZ550985A patent/NZ550985A/en not_active IP Right Cessation
- 2005-05-20 ES ES05743594T patent/ES2368155T3/es not_active Expired - Lifetime
- 2005-05-20 US US11/596,089 patent/US7745623B2/en not_active Expired - Fee Related
- 2005-05-20 CN CN2010105739971A patent/CN102093285B/zh not_active Expired - Fee Related
- 2005-05-20 CN CN2005800244522A patent/CN1989104B/zh not_active Expired - Fee Related
- 2005-05-20 PT PT05743594T patent/PT1748985E/pt unknown
- 2005-05-20 MY MYPI20052298A patent/MY154461A/en unknown
- 2005-05-20 AU AU2005245298A patent/AU2005245298B2/en not_active Ceased
- 2005-05-20 RS RS20110371A patent/RS51925B/sr unknown
- 2005-05-20 JP JP2007521014A patent/JP4129047B2/ja not_active Expired - Fee Related
- 2005-05-20 MX MXPA06013243A patent/MXPA06013243A/es active IP Right Grant
- 2005-05-20 PH PH1/2012/501331A patent/PH12012501331A1/en unknown
- 2005-05-20 CA CA2567506A patent/CA2567506C/en not_active Expired - Fee Related
- 2005-05-20 KR KR1020067023942A patent/KR101248637B1/ko not_active Expired - Fee Related
- 2005-05-20 WO PCT/JP2005/009711 patent/WO2005113504A1/en not_active Ceased
- 2005-05-20 DK DK05743594.3T patent/DK1748985T3/da active
- 2005-05-20 EP EP10161428.7A patent/EP2208726B1/en not_active Expired - Lifetime
- 2005-05-20 PL PL05743594T patent/PL1748985T3/pl unknown
- 2005-05-20 HR HR20110640T patent/HRP20110640T1/hr unknown
- 2005-05-20 RU RU2006145449/04A patent/RU2361861C2/ru not_active IP Right Cessation
-
2006
- 2006-10-26 IL IL178896A patent/IL178896A/en not_active IP Right Cessation
- 2006-12-20 NO NO20065929A patent/NO20065929L/no not_active Application Discontinuation
-
2008
- 2008-01-15 JP JP2008006003A patent/JP4362535B2/ja not_active Expired - Fee Related
- 2008-06-11 US US12/157,574 patent/US20080255352A1/en not_active Abandoned
- 2008-06-11 US US12/157,573 patent/US20080255362A1/en not_active Abandoned
-
2010
- 2010-03-02 US US12/715,930 patent/US8697865B2/en not_active Expired - Fee Related
-
2011
- 2011-09-15 CY CY20111100894T patent/CY1111850T1/el unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HRP20110640T1 (hr) | Derivati cikličkih amida i njihova proizvodnja te njihova uporaba kao antitromboznih sredstava | |
| HRP20090471T1 (hr) | Derivati prolina i njihova upotreba kao inhibitori dipeptidil-peptidaze iv | |
| NZ594765A (en) | Anthelmintic agents and their use | |
| FI3555064T3 (fi) | Glp-1-reseptoriagonisteja ja niiden käyttöjä | |
| CY1108428T1 (el) | Μονοϋδροχλωρικο αλας 1-[3 [3-(4-χλωροφαινυλ) προποξυ] προπυλ] - πιπεριδινης | |
| ZA201301560B (en) | Crystalliine (r)-(e)-2-(4-(2-(5-(1-(3,5-dichloropyridin-4-yl)ethoxy)-1h-indazol-3-yl)vinyl)-1h-pyrazol-1-yl)ethanol and its use as fgrfr inhibitor | |
| JP2010507641A5 (en:Method) | ||
| ATE502937T1 (de) | Neue polymorphe form von 5-chlor-n-(ä ( 5s )-2- 0x0-3-ä4-( 3-oxo-4-morpholinyl)-phenylü-1,3- oxazolidin-5-ylü -methyl)-2-thiophencarboxamid | |
| NZ620635A (en) | Compounds for binding to the platelet specific glycoprotein iib/iiia and their use for imaging of thrombi | |
| HRP20120969T1 (hr) | Spoj azola | |
| JP2010519243A5 (en:Method) | ||
| IL195511A0 (en) | 1-[2-(2,4-dimethylphenylsulfanyl)-phenyl] | |
| MA28476B1 (fr) | 5-6-dialkyl-7-amino-triazolopyrimidines, procede pour fabriquer ces composes et leur utilisation pour lutter contre les champignons et des agents les contenant | |
| MA28523B1 (fr) | 5-6-dialkyl-7-amino-triazolopyrimidines, procede pour fabriquer ces composes et leur utilisation pour lutter contre des champignons nuisibles et des agents les contenant | |
| JP2009535362A5 (en:Method) | ||
| PE20090898A1 (es) | Pirrolidina-aril-eteres como antagonistas de receptor de nk3 | |
| JP2004043453A5 (en:Method) | ||
| WO2009010429A3 (en) | Novel heterocyclyl compounds and their use as chemokine antagonists | |
| NO20075022L (no) | (7-(2-(4-(3-trifluormetylfenyl)-1,2,3,6-tetrahydropyrid-1-yl)etyl) isokinolinbesylatsalt, fremstilling og terapeutiske anvendelser derav | |
| ZA200903578B (en) | Novel intermediate and process useful in the preparation of {2-[1-(3,5-bis-trifluoromethyl-benzyl)-5-pyridin-4-yl-1h-[1,2,3]triazol-4-yl]-pyridin-3-yl}-(2-chlorophenyl)-methanone | |
| JP2008516922A5 (en:Method) | ||
| JP2002507613A5 (en:Method) | ||
| JP2007533735A5 (en:Method) | ||
| NO20044999L (no) | Polymorf av 4-[2-[4-[1-(2-etoksyetyl)-1H-benzimidazol-2-yl]-1-piperidinyl]etyl]-alfa,alfa-dimetyl-benzeneddiksyre | |
| JP2010539152A5 (en:Method) |